Market Research Logo

Avascular Necrosis Market - Size, Share, Trends, and Forecast to 2026

Avascular Necrosis Market - Size, Share, Trends, and Forecast to 2026

Avascular necrosis (AVN), also called osteonecrosis, ischemic bone necrosis, or aseptic necrosis, is a condition that occurs due to loss of blood flow to the bone. The condition mostly occurs in the hip however, other common sites include ankle, knee, and shoulder. Individuals between the age of 20 and 50 years are more susceptible to avascular necrosis. Most cases of avascular necrosis occur due to an underlying health problem or injury. Moreover, factors such as increased intake of corticosteroids and alcohol may cause fatty substances to build in the blood vessels and decrease the blood supply to the bones, eventually causing avascular necrosis. Treatment for this condition depends on a number of factors, including age, disease stage, location, and amount of bone damage.

Market Dynamics

Growth of avascular necrosis market is primarily driven by factors such as increasing incidence of avascular necrosis, high demand for non-invasive treatment, and increasing dependence on surgery to cure avascular necrosis. According to Bone Therapeutics report in 2017, around 170,000 patients were suffering from avascular necrosis in the U.S., Europe, and Japan. Moreover, side effects from various medicines taken during cancer, HIV/AIDS, osteoporosis, osteoarthritis, blood disorders, or medical treatment such as chemotherapy, radiation therapy, high-dosage of steroids, and organ transplants can increase chances of developing avascular necrosis. However, delay in diagnosis due to asymptomatic nature of this condition at early stage and high cost of surgical treatments for avascular necrosis are the major factors hampering growth of the avascular necrosis market.

Key features of the study:

This report provides in-depth analysis of the avascular necrosis market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global avascular necrosis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Bone Therapeutics, Boehringer Ingelheim GmbH, Bayer AG, Enzo Biochem Inc., Ethicon Inc., Eli Lilly and Company, Grifols SA, Integra LifeSciences Corporation, K-Stemcell Co Ltd., Medtronic Plc, Merck KGaA, Pfizer Inc., Sanofi SA, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global avascular necrosis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for avascular necrosis products, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:

Global Avascular Necrosis Market, By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
Global Avascular Necrosis Market, By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Global Avascular Necrosis Market, By Region:
North America
By Country:
U.S.
Canada
By Type:
Trauma  Related  Avascular  Necrosis
Non-Trauma  Related  Avascular  Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Type:
Trauma  Related  Avascular  Necrosis
Non-Trauma  Related  Avascular  Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Type:
Trauma  Related  Avascular  Necrosis
Non-Trauma  Related  Avascular  Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Type:
Trauma  Related  Avascular  Necrosis
Non-Trauma  Related  Avascular  Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type:
Trauma  Related  Avascular  Necrosis
Non-Trauma  Related  Avascular  Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Africa
By Country:
South Africa
Central Africa
North Africa
By Type:
Trauma  Related  Avascular  Necrosis
Non-Trauma  Related  Avascular  Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Company Profiles
Bone Therapeutics*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Boehringer Ingelheim GmbH
Bayer AG
Enzo Biochem Inc.
Ethicon Inc.
Eli Lilly and Company
Grifols SA
Integra LifeSciences Corporation
K-Stemcell Co Ltd.
Medtronic Plc
Merck KGaA
Pfizer Inc.
Sanofi SA
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings
“*” marked represents similar segmentation in other categories in the respective section.


Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Treatment
Market Snippet, By Region
Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technological Advancements
Epidemiology Analysis
PEST Analysis
Pipeline Analysis
Global Avascular Necrosis Market, By Type, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2016 – 2026
Segment Trends
Trauma  Related  Avascular  Necrosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Non-Trauma  Related  Avascular  Necrosis
Introduction  
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Global Avascular Necrosis Market, By Treatment, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2016 – 2026
Segment Trends
Drug-Based
 Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Surgery-Based
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Global Avascular Necrosis Market, By Region, 2016 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2016 – 2026
Regional Trends
North America
Market Size and Forecast, By Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
Competitive Landscape
Heat Map Analysis
Company Profiles
Bone Therapeutics
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Boehringer Ingelheim GmbH
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bayer AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Enzo Biochem Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Ethicon Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Eli Lilly and Company
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Grifols SA
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Integra LifeSciences Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
K-Stemcell Co Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Medtronic Plc
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck KGaA
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sanofi SA
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Stryker Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Wright Medical Group N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Zimmer Biomet Holdings
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
Section
References
Research Methodology
About us and Sales Contact
*Browse 17 market data tables and 21 figures on "Avascular Necrosis Market” - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report